Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 4

Sponsor Class

OTHER 3NETWORK 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 13Genitourinary 11Gastrointestinal 9Breast 9Thoracic 4Sarcoma 4Plasma cell 4Lymphoid 4Head & Neck 4Gynecologic 3Other solid neoplasm 2Myeloid 2Dermatologic 2Classical hematology 1CNS 1

Conditions

Multiple Myeloma 4Neoplasms, Plasma Cell 3Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Fanconi Anemia 1

Interventions

Dexamethasone 392Bortezomib 245Lenalidomide 220Cyclophosphamide 184Melphalan 168Calcium Dobesilate 119Peripheral Blood Stem Cell Transplantation 94fludarabine phosphate 89Thalidomide 82Filgrastim 74carfilzomib 70pomalidomide 68Granulocyte Colony-Stimulating Factor 63Busulfan 63Mycophenolic Acid 61daratumumab 57Whole-Body Irradiation 57ixazomib 54fludarabine 52Tacrolimus 52Prednisone 51Cyclosporine 50Antilymphocyte Serum 35dexamethasone acetate 32plerixafor 30Etoposide 30Methotrexate 29Radiotherapy 28dexamethasone 21-phosphate 27Doxorubicin 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Reverse Transcriptase Polymerase Chain Reaction × Plasma cell × Clear all
NCT00900055 2022-07-05

Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma

OHSU Knight Cancer Institute

Completed
213 enrolled
Classical hematologyMyeloidPlasma cell

Fanconi Anemia, Multiple Myeloma, Myeloproliferative Disorders, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases

NCT01155583 2020-11-16

Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma

Case Comprehensive Cancer Center

Phase 1/2 Completed
45 enrolled 20 charts
Plasma cell

Multiple Myeloma

NCT00899080 2017-05-17

Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide

Eastern Cooperative Oncology Group

Completed
33 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00616720 2011-05-16

Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma

Mayo Clinic

Phase 2 Completed
15 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡